Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (Q167209)
From geokb
Study of CLL's genetic mutations and treatment options.
- Chronic Lymphocytic Leukemia
- Genomic Aberrations
- BTK Inhibitors
- Rituximab
- Ibrutinib
- Prognostic Factors
- TP53 Mutation
- Waldenström Macroglobulinemia
- Immunoglobulin Mutation
- Therapeutic Targets
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia |
Study of CLL's genetic mutations and treatment options. |
|
